These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36718801)

  • 1. Insertable cardiac monitor-guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM-REDUCE-AF trial).
    Tankut SS; Huang DT; Zareba W; Aktas MK; Rosero SZ; Steinberg J; Henchen J; Kutyifa V; Strawderman RL; Goldenberg I
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13043. PubMed ID: 36718801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Cardiac Monitoring around Atrial Fibrillation Ablation: Insights on Clinical Classifications and End Points.
    Dekker LR; Pokushalov E; Sanders P; Lindborg KA; Maus B; Pürerfellner H
    Pacing Clin Electrophysiol; 2016 Aug; 39(8):805-13. PubMed ID: 27226200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study.
    Assaf A; Theuns DAMJ; Sakhi R; Bhagwandien RE; Szili-Torok T; Yap SC
    Ann Noninvasive Electrocardiol; 2022 May; 27(3):e12960. PubMed ID: 35481956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: an observational study through a subcutaneous leadless cardiac monitor.
    Pedrote A; Arana-Rueda E; García-Riesco L; Sánchez-Brotons J; Durán-Guerrero M; Gómez-Pulido F; Arce-León A; Frutos-López M
    J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1075-82. PubMed ID: 23790041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: The CLOSE to CURE study.
    Duytschaever M; De Pooter J; Demolder A; El Haddad M; Phlips T; Strisciuglio T; Debonnaire P; Wolf M; Vandekerckhove Y; Knecht S; Tavernier R
    Heart Rhythm; 2020 Apr; 17(4):535-543. PubMed ID: 31707159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are implantable cardiac monitors the 'gold standard' for atrial fibrillation detection? A prospective randomized trial comparing atrial fibrillation monitoring using implantable cardiac monitors and DDDRP permanent pacemakers in post atrial fibrillation ablation patients.
    Podd SJ; Sugihara C; Furniss SS; Sulke N
    Europace; 2016 Jul; 18(7):1000-5. PubMed ID: 26585596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early atrial fibrillation recurrence post catheter ablation: Analysis from insertable cardiac monitor in the era of optimized radiofrequency ablation.
    De Becker B; El Haddad M; De Smet M; François C; Tavernier R; le Polain de Waroux JB; Duytschaever M; Knecht S
    Heart Rhythm; 2024 May; 21(5):521-529. PubMed ID: 38246570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of persistent atrial fibrillation: anatomically based circumferential pulmonary vein ablation in combination with a potential-guided segmental approach to achieve complete pulmonary vein isolation.
    Kettering K; Weig HJ; Busch M; Schneider KM; Eick C; Weretka S; Laszlo R; Gawaz M; Schreieck J
    J Interv Card Electrophysiol; 2011 Jan; 30(1):63-72. PubMed ID: 21253841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term comparisons of atrial fibrillation ablation outcomes with a cryoballoon or laser-balloon: A propensity-matched analysis based on continuous rhythm monitoring.
    Schiavone M; Gasperetti A; Montemerlo E; Pozzi M; Sabato F; Piazzi E; Ruggiero D; De Ceglia S; Viecca M; Calkins H; Rovaris G; Forleo GB
    Hellenic J Cardiol; 2022; 65():1-7. PubMed ID: 35331905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
    Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Catheter Ablation on Arrhythmia Burden in Patients With Shock-Resistant Persistent Atrial Fibrillation.
    O'Neill L; Almorad A; El Haddad M; Wielandts JY; Gillis K; Hilfiker G; de Becker B; Lycke M; Tavernier R; le Polain de Waroux JB; Duytschaever M; Knecht S
    JACC Clin Electrophysiol; 2023 Oct; 9(10):2071-2081. PubMed ID: 37542487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Monitoring Strategy on Assessment of Ablation Success and Postablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design.
    Aguilar M; Macle L; Deyell MW; Yao R; Hawkins NM; Khairy P; Andrade JG
    Circulation; 2022 Jan; 145(1):21-30. PubMed ID: 34816727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic and asymptomatic long-term recurrences following transcatheter atrial fibrillation ablation.
    Manganiello S; Anselmino M; Amellone C; Pelissero E; Giuggia M; Trapani G; Giordano B; Senatore G; Gaita F
    Pacing Clin Electrophysiol; 2014 Jun; 37(6):697-702. PubMed ID: 24665920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.
    Nery PB; Wells GA; Verma A; Joza J; Nair GM; Veenhuyzen G; Andrade J; Nault I; Wong JA; Sikkel M; Essebag V; Macle L; Sapp J; Roux JF; Skanes A; Angaran P; Novak P; Redfearn D; Golian M; Redpath CJ; Sturmer M; Birnie D
    Am Heart J; 2022 Dec; 254():133-140. PubMed ID: 36030965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ganglionated plexi ablation in addition to pulmonary vein isolation for paroxysmal versus persistent atrial fibrillation: a meta-analysis of randomized controlled clinical trials.
    Kampaktsis PN; Oikonomou EK; Y Choi D; Cheung JW
    J Interv Card Electrophysiol; 2017 Dec; 50(3):253-260. PubMed ID: 28887742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study.
    Pokushalov E; Romanov A; Corbucci G; Artyomenko S; Turov A; Shirokova N; Karaskov A
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):823-31. PubMed ID: 21930653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial.
    Kuck KH; Hoffmann BA; Ernst S; Wegscheider K; Treszl A; Metzner A; Eckardt L; Lewalter T; Breithardt G; Willems S;
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003337. PubMed ID: 26763226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial).
    Osmancik P; Havránek Š; Bulková V; Chovančík J; Roubíček T; Heřman D; Čarná Z; Tuka V; Matoulek M; Fiala M; Jiravský O; Stregl-Hruskova S; Latiňák A; Kotryová J; Jarkovský J
    BMJ Open; 2022 Jun; 12(6):e056522. PubMed ID: 35705334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of left atrial low-voltage area guided ablation for recurrence prevention compared to pulmonary vein isolation alone in patients with persistent atrial fibrillation trial: Design and rationale.
    Sunaga A; Masuda M; Inoue K; Tanaka N; Watanabe T; Furukawa Y; Egami Y; Hirata A; Makino N; Minamiguchi H; Oka T; Minamisaka T; Takeda T; Yamada T; Kitamura T; Kida H; Oeun B; Sato T; Sotomi Y; Dohi T; Okada K; Suna S; Mizuno H; Nakatani D; Hikoso S; Sakata Y;
    Clin Cardiol; 2021 Sep; 44(9):1249-1255. PubMed ID: 34291484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmented wide area circumferential catheter ablation for reduction of atrial fibrillation recurrence (AWARE) trial: Design and rationale.
    Nair GM; Birnie DH; Wells GA; Nery PB; Redpath CJ; Sarrazin JF; Roux JF; Parkash R; Bernier M; Sterns LD; Novak P; Veenhuyzen G; Morillo CA; Singh SM; Sturmer M; Chauhan VS; Angaran P; Essebag V
    Am Heart J; 2022 Jun; 248():1-12. PubMed ID: 35219715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.